IDEAS home Printed from https://ideas.repec.org/p/boc/econ25/06.html
   My bibliography  Save this paper

Do GLP-1 medications pay for themselves?

Author

Listed:
  • Kosali Simon

    (Indiana University)

  • Coady Wing
  • Sih-Ting Cai
  • Daniel Sacks

Abstract

GLP-1 drugs have demonstrated tremendous health effects in clinical trials, suggesting that some of their high price may be offset by reduced spending on other forms of healthcare. We use commercial insurance claims data to study the effects of GLP-1 initiation on subsequent downstream health expenditures. We focus on individuals with a type 2 diabetes diagnosis who are continuously enrolled in a commercial plan for eight years and who are prescribed a GLP-1 medication at some point between 2018 and 2023. We use a stacked difference-in-differences design to compare healthcare spending of earlier GLP-1 adopters to later GLP-1 adopters, allowing us to estimate the impact of initiation while controlling for underlying time trends and baseline characteristics.

Suggested Citation

Handle: RePEc:boc:econ25:06
as

Download full text from publisher

File URL: http://repec.org/econ2025/
File Function: presentation materials
Download Restriction: no
---><---

More about this item

Statistics

Access and download statistics

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:boc:econ25:06. See general information about how to correct material in RePEc.

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

We have no bibliographic references for this item. You can help adding them by using this form .

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://edirc.repec.org/data/stataea.html .

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.